CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 103 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,072,802 | +89.4% | 27,923 | +14.1% | 0.01% | +75.0% |
Q1 2023 | $566,411 | -9.8% | 24,467 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $628,276 | +35.1% | 23,980 | +1.3% | 0.00% | +33.3% |
Q3 2022 | $465,000 | +29.9% | 23,674 | +15.8% | 0.00% | +50.0% |
Q2 2022 | $358,000 | +9.1% | 20,445 | +2.1% | 0.00% | 0.0% |
Q1 2022 | $328,000 | -3.2% | 20,029 | -3.5% | 0.00% | 0.0% |
Q4 2021 | $339,000 | +46.8% | 20,766 | +14.6% | 0.00% | +100.0% |
Q3 2021 | $231,000 | -7.2% | 18,121 | +2.8% | 0.00% | 0.0% |
Q2 2021 | $249,000 | +107.5% | 17,622 | +127.7% | 0.00% | – |
Q1 2021 | $120,000 | -1.6% | 7,738 | +0.3% | 0.00% | – |
Q4 2020 | $122,000 | – | 7,717 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |